Neuraxis grants CFO 141K RSUs at $6.28 each

Henrichs Timothy Robert reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Henrichs Timothy Robert reported acquisition or exercise transactions in this Form 4 filing.

Neuraxis, Inc. (NRXS) reported an equity compensation grant to its Chief Financial Officer, Timothy Robert Henrichs. He received 141,479 RSUs, representing the right to receive an equal number of shares of common stock. The award was valued at $6.28 per unit for reporting purposes and was granted under the Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs vest in three equal annual installments over three years, and the filing shows Henrichs holding 141,479 shares/units directly following this award.

Insider Trade Summary

Grant/Award: 141,479 shares

Grant/Award 1 txn

Insider Henrichs Timothy Robert

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	RSU F1	141,479	$6.28	$888K

Holdings After Transaction: RSU — 141,479 contracts (Direct)

Footnotes (1)

1. F1. These shares of common stock are restricted stock units (RSUs) granted to the reporting person under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs vest in three equal annual installments over a three-year period.

Key Figures

RSUs Granted: 141,479 shares Grant Value per RSU: $6.28 per share Shares Following Transaction: 141,479 shares +1 more

4 metrics

RSUs Granted 141,479 shares Restricted stock units granted to CFO on 2026-08-13

Grant Value per RSU $6.28 per share Per-unit value used for the RSU award to the CFO

Shares Following Transaction 141,479 shares Total direct holdings reported after the RSU grant

Vesting Schedule 3 annual installments over 3 years RSUs vest in three equal annual installments

Key Terms

restricted stock units (RSUs), 2022 Omnibus Securities and Incentive Plan, vest, derivative

4 terms

restricted stock units (RSUs) financial

"These shares of common stock are restricted stock units (RSUs) granted to the reporting person"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

2022 Omnibus Securities and Incentive Plan financial

"granted to the reporting person under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan"

vest financial

"The RSUs vest in three equal annual installments over a three-year period"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

derivative financial

"transaction_type": "derivative""

A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity award did NRXS grant to its Chief Financial Officer?

Neuraxis (NRXS) granted its CFO 141,479 restricted stock units (RSUs). Each RSU represents one share of common stock, awarded as part of equity compensation under the company’s 2022 Omnibus Securities and Incentive Plan.

At what value were the NRXS RSUs granted to the CFO recorded?

The RSUs granted to the NRXS CFO were recorded at $6.28 per unit. This figure is used for reporting purposes in the Form 4 and reflects a per-share valuation for the 141,479 RSUs.

How do the NRXS RSUs granted to the CFO vest over time?

The CFO’s Neuraxis (NRXS) RSUs vest in three equal annual installments over a three-year period. This means one-third of the 141,479 units becomes vested each year, subject to the plan’s terms.

How many NRXS shares or units does the CFO hold after this RSU grant?

After this grant, the Form 4 reports the CFO holding 141,479 shares/units directly. This reflects the total RSU-based common stock position shown as of the transaction date in the filing.

Under which plan were the NRXS RSUs granted to the CFO?

The RSUs for the NRXS CFO were granted under the Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. This plan governs terms such as vesting, award structure, and eligibility.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/17/2026 - 06:30 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Henrichs Timothy Robert

(Last) (First) (Middle)

11611 N. MERIDIAN ST, SUITE 330

(Street)

CARMEL INDIANA 46032

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Neuraxis, INC [ NRXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
RSU	(1)	08/13/2026		A		141,479		(1)	(1)	Common Stock	141,479	$6.28	141,479	D

Explanation of Responses:

1. These shares of common stock are restricted stock units (RSUs) granted to the reporting person under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs vest in three equal annual installments over a three-year period.

	/s/ Timothy Henrichs	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)